Modulators of Plexin B2 activity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 31, 2016
Grant Date -
Apr 17, 2014
app pub date -
Mar 28, 2012
filing date -
Mar 28, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed herein are novel compositions and methods for the inhibition of Plexin B2-mediated Angiogenin activity. Such compositions and methods are useful, for example, for the treatment of cancer, the treatment of wet AMD and the inhibition of angiogenesis. Also disclosed herein are methods of determining whether a test agent is a modulator of Plexin B2 activity.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully